Michael W Traxlmayr

9PUBLICATIONS
55CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Protein traffickingPredictive and prognostic markersIndustrial molecular engineering of nucleic acids and proteinsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 10, 2026
Balancing the efficacy and safety of chimeric antigen receptor T-cell therapy by affinity combination.

Linda Warmuth, Sarah Dötsch, Manuel Trebo

|Oct 17, 2025
Protein palmitoylation and sphingolipid metabolism control regulated exocytosis in cytotoxic lymphocytes.

Artem Kalinichenko, Jakob Huemer, Theresa Humer

|Sep 23, 2022
Identification of Activating Mutations in the Transmembrane and Extracellular Domains of EGFR.

Anja Wagner, Edgar Galicia-Andrés, Magdalena Teufl

|Mar 08, 2022
Engineering Strategies to Overcome the Stability-Function Trade-Off in Proteins.

Magdalena Teufl, Charlotte U Zajc, Michael W Traxlmayr

|Aug 22, 2020
Engineering AvidCARs for combinatorial antigen recognition and reversible control of CAR function.

Benjamin Salzer, Christina M Schueller, Charlotte U Zajc

|Aug 15, 2020
Driving CARs with alternative navigation tools - the potential of engineered binding scaffolds.

Charlotte U Zajc, Benjamin Salzer, Joseph M Taft

Pageof 2

Frequent Collaborators

5 joint publications

Charlotte U Zajc

3 joint publications

Benjamin Salzer

3 joint publications

Manfred Lehner

2 joint publications

Jacqueline Seigner